Michael E. Augustyniak

Synthesis and Selective Cyclooxygenase-2 Inhibitory Activity of a Series of Novel, Nitric Oxide Donor-Containing Pyrazoles

Ramani R. Ranatunge, Michael E. Augustyniak, Upul K. Bandarage et al. · Journal of Medicinal Chemistry · 2004 · 76 citations · Full text

Medicinal Chemistry, Selective Cox-2 Inhibitor, Biochemistry +13

Structure-Based Design, Synthesis, and Biological Evaluation of Indomethacin Derivatives as Cyclooxygenase-2 Inhibiting Nitric Oxide Donors

Shiow‐Jyi Wey, Michael E. Augustyniak, Edward Cochran et al. · Journal of Medicinal Chemistry · 2007 · 55 citations · Full text

Combinatorial Chemistry, Nitrates 32, Bioorganic Chemistry +18

Synthesis and anti-inflammatory activity of a series of N-substituted naproxen glycolamides: Nitric oxide-donor naproxen prodrugs

Ramani R. Ranatunge, Michael E. Augustyniak, Vijay Dhawan et al. · Bioorganic & Medicinal Chemistry · 2005 · 27 citations

Medicinal Chemistry, Pharmaceutical Science, Anti-inflammatory +9

3-[4-(Methylsulfonyl)phenyl]-5-(trifluoromethyl)(2-pyridyl) Phenyl Ketone as a Potent and Orally Active Cyclooxygenase-2 Selective Inhibitor:  Synthesis and Biological Evaluation

Subhash P. Khanapure, Michael E. Augustyniak, Richard A. Earl et al. · Journal of Medicinal Chemistry · 2005 · 14 citations · Full text

Results of a phase I study in patients suffering from secondary-progressive multiple sclerosis demonstrating the safety of the amino acid copolymer PI-2301 and a possible induction of an anti-inflammatory cytokine response☆

Joseph Kovalchin, Jeffrey Krieger, Michelle Genova et al. · Journal of Neuroimmunology · 2010 · 11 citations · Full text

Inflammation, Possible Induction, Autoimmune Disease +10